DK0549331T3 - Tilførselsanordning til styret lægemiddelafgivelse - Google Patents

Tilførselsanordning til styret lægemiddelafgivelse

Info

Publication number
DK0549331T3
DK0549331T3 DK92311716.2T DK92311716T DK0549331T3 DK 0549331 T3 DK0549331 T3 DK 0549331T3 DK 92311716 T DK92311716 T DK 92311716T DK 0549331 T3 DK0549331 T3 DK 0549331T3
Authority
DK
Denmark
Prior art keywords
hydration
delivery device
drug delivery
controlled drug
gelatinous
Prior art date
Application number
DK92311716.2T
Other languages
Danish (da)
English (en)
Inventor
Gerald S Rork
James D Pipkin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0549331T3 publication Critical patent/DK0549331T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92311716.2T 1991-12-27 1992-12-22 Tilførselsanordning til styret lægemiddelafgivelse DK0549331T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (1)

Publication Number Publication Date
DK0549331T3 true DK0549331T3 (da) 1997-09-15

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92311716.2T DK0549331T3 (da) 1991-12-27 1992-12-22 Tilførselsanordning til styret lægemiddelafgivelse

Country Status (26)

Country Link
EP (1) EP0549331B1 (sr)
JP (1) JPH089534B2 (sr)
KR (1) KR100281609B1 (sr)
CN (1) CN1074368A (sr)
AT (1) ATE157001T1 (sr)
AU (1) AU660057B2 (sr)
BG (1) BG61751B1 (sr)
CA (1) CA2085871C (sr)
CZ (1) CZ284045B6 (sr)
DE (1) DE69221711T2 (sr)
DK (1) DK0549331T3 (sr)
ES (1) ES2106838T3 (sr)
FI (1) FI109451B (sr)
GR (1) GR3024885T3 (sr)
HU (1) HU219594B (sr)
IL (1) IL104189A (sr)
LV (1) LV12082B (sr)
MX (1) MX9207541A (sr)
NO (1) NO310672B1 (sr)
NZ (1) NZ245514A (sr)
PL (1) PL171110B1 (sr)
RO (1) RO112810B1 (sr)
RU (1) RU2127586C1 (sr)
SK (1) SK279964B6 (sr)
WO (1) WO1993012765A1 (sr)
YU (1) YU48762B (sr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
HU224224B1 (hu) * 1997-01-14 2005-06-28 Lts Lohmann Therapie-Systeme Gmbh Expandálható gasztroretentív terápiás rendszer szabályozott hatóanyagfelszabadulással a gyomor-bél traktusban
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
ATE244558T1 (de) 1999-04-16 2003-07-15 Novo Nordisk As Trockene formbare arzneistoffformulierung
EP1308160A4 (en) * 2000-08-08 2005-01-19 Daiichi Seiyaku Co STRONG ABSORBABLE SOLID PREPARATION
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
WO2003051328A1 (en) * 2001-12-18 2003-06-26 Novo Nordisk A/S Solid dose micro implant
US20030153617A1 (en) * 2001-12-18 2003-08-14 Dalen Frans Van Simvastatin dosage forms
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
RU2005108608A (ru) * 2002-09-28 2005-10-27 МакНЕЙЛ-ППС, ИНК. (US) Дозированная форма немедленного высвобождения, содержащая оболочку с отверстиями
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
WO2006014434A2 (en) 2004-07-02 2006-02-09 Eliot Lazar Treatment medium delivery device and methods for delivery
CN103393496B (zh) 2006-03-31 2016-08-17 玛提治疗有限公司 用于药物治疗的鼻泪引流系统植入物
WO2009035571A2 (en) 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Lacrimal implant detection
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
ES2727203T3 (es) 2011-08-29 2019-10-14 Mati Therapeutics Inc Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
JP2020066606A (ja) * 2018-10-25 2020-04-30 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
IL104189A (en) 1996-10-31
RU2127586C1 (ru) 1999-03-20
KR940703653A (ko) 1994-12-12
NZ245514A (en) 1994-12-22
HUT70437A (en) 1995-10-30
SK279964B6 (sk) 1999-06-11
RU94031474A (ru) 1997-04-20
YU48762B (en) 1999-11-22
DE69221711D1 (de) 1997-09-25
EP0549331A1 (en) 1993-06-30
YU111292A (sh) 1995-12-04
RO112810B1 (ro) 1998-01-30
NO942430L (no) 1994-06-27
GR3024885T3 (en) 1998-01-30
ES2106838T3 (es) 1997-11-16
AU3034892A (en) 1993-08-12
WO1993012765A1 (en) 1993-07-08
DE69221711T2 (de) 1998-03-12
CZ284045B6 (cs) 1998-07-15
NO310672B1 (no) 2001-08-13
SK76994A3 (en) 1995-05-10
FI943011A0 (fi) 1994-06-22
KR100281609B1 (ko) 2001-02-15
JPH089534B2 (ja) 1996-01-31
ATE157001T1 (de) 1997-09-15
FI943011A (fi) 1994-06-22
CA2085871C (en) 2002-05-07
MX9207541A (es) 1994-06-30
JPH05255071A (ja) 1993-10-05
FI109451B (fi) 2002-08-15
EP0549331B1 (en) 1997-08-20
HU9401913D0 (en) 1994-09-28
IL104189A0 (en) 1993-05-13
HU219594B (hu) 2001-05-28
AU660057B2 (en) 1995-06-08
NO942430D0 (no) 1994-06-27
BG98805A (bg) 1995-03-31
CZ157094A3 (en) 1994-12-15
PL171110B1 (pl) 1997-03-28
LV12082B (en) 1998-09-20
LV12082A (lv) 1998-07-20
BG61751B1 (bg) 1998-05-29
CA2085871A1 (en) 1993-06-28
CN1074368A (zh) 1993-07-21

Similar Documents

Publication Publication Date Title
DK0549331T3 (da) Tilførselsanordning til styret lægemiddelafgivelse
DK0801560T3 (da) En kontrolleret lægemiddelfrigivelsessuspensions-tilførselsanordning
DK0550641T3 (da) Dispenseringsanordning indeholdende et hydrofobt medium
ATE230980T1 (de) Formulierungen mit verzögerter freisetzung zur abgabe von metoprolol über 24 stunden
ATE345781T1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
ATE176379T1 (de) Versprühbare filmbildende wirkstoffabgabesysteme zur anwendung an pflanzen
IS6863A (is) Ný himnuhúð
CA2222359A1 (fr) Composition cosmetique comprenant l'association d'un polymere filmogene et d'une dispersion de cire et utilisation de ladite association
AU7267191A (en) Method for coating active principles with a ph-sensitive polymer
FI101855B1 (fi) Menetelmä asetatsolamidia jatkuvasti vapauttavan asetatsolamidivalmisteen valmistamiseksi
YU47887B (sh) Postupak za pravljenje čvrstog farmaceutskog preparata za oslobadjanje aktivne supstance
CA2206211A1 (en) A controlled release drug suspension delivery device